Dr. Rolf Soiron to step down as Chairman of the Board of Nobel Biocare at the latest by the 2010 Annual General Meeting

Zurich, Switzerland, (PresseBox) - Dr. Rolf Soiron, Chairman of the Board of Directors (non-executive) of Nobel Biocare, has announced his intentions to step down from this position at the latest by the Annual General Meeting on 25 March 2010. Dr. Soiron has recently taken over the position of President of the Foundation Board of the think tank Avenir Suisse and furthermore has been elected to the International Committee of the Red Cross. This early announcement gives the Board of Directors the opportunity to carefully prepare for Dr. Soiron's succession.

Says Dr. Soiron, Chairman of Nobel Biocare, "Nobel Biocare is a profitable and financially healthy company, even in these economically challenging times. A change in the position of Chairman is now possible because, under the leadership of CEO Domenico Scala, the measures needed to again bring the company to the forefront of the dental sector and on a growth path are making very good progress. The newly formed management put together under Mr. Scala's leadership and the initiatives he has taken are building the foundation for a new, successful phase in the company's development."

Nobel Biocare Deutschland GmbH

Nobel Biocare is a medical devices group and the world leader in innovative esthetic dental solutions with its key brands NobelActive(TM) , Brånemark System®, NobelReplace(TM) , NobelSpeedy(TM) , Replace Select (dental implants), NobelProcera(TM) (individualized dental prosthetics), NobelGuide(TM) (complete patient rehabilitation program) and NobelSmile(TM) (patient education and awareness program). Nobel Biocare is a full solution provider for restorative esthetic dentistry, offering a wide range of innovative Crown & Bridge & Implant products, as well as training and education, patient information and clinically documented treatment concepts. Nobel Biocare has over 2,500 employees and recorded revenue of EUR 619.2 million in 2008. The Company is domiciled and headquartered in Zurich, Switzerland. Production takes place at six production sites located in Sweden, the US, Japan and Israel. Nobel Biocare has 37 direct sales organizations. The shares of the parent company Nobel Biocare Holding AG are listed on the SIX Swiss Exchange.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.